Elsevier

Fertility and Sterility

Volume 95, Issue 3, 1 March 2011, Pages 857-866
Fertility and Sterility

Special contribution
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome

https://doi.org/10.1016/j.fertnstert.2010.09.006Get rights and content
Under an Elsevier user license
open archive

Objective

To improve the interpretation of future studies in women who are initially diagnosed with a pregnancy of unknown location (PUL), we propose a consensus statement with definitions of population, target disease, and final outcome.

Design

A review of literature and a series of collaborative international meetings were used to develop a consensus for definitions and final outcomes of women initially diagnosed with a PUL.

Result(s)

Global differences were noted in populations studied and in the definitions of outcomes. We propose to define initial ultrasound classification of findings into five categories: definite ectopic pregnancy (EP), probable EP, PUL, probable intrauterine pregnancy (IUP), and definite IUP. Patients with a PUL should be followed and final outcomes should be categorized as visualized EP, visualized IUP, spontaneously resolved PUL, and persisting PUL. Those with the transient condition of a persisting PUL should ultimately be classified as nonvisualized EP, treated persistent PUL, resolved persistent PUL, or histologic IUP. These specific categories can be used to characterize the natural history or location (intrauterine vs. extrauterine) of any early gestation where the initial location is unknown.

Conclusion(s)

Careful definition of populations and classification of outcomes should optimize objective interpretation of research, allow objective assessment of future reproductive prognosis, and hopefully lead to improved clinical care of women initially identified to have a PUL.

Key Words

Nomenclature
pregnancy of unknown location
international consensus
ectopic pregnancy

Cited by (0)

K.B. has nothing to disclose. N.M.v.M. has nothing to disclose. T.B. has nothing to disclose. E.K. has nothing to disclose. B.V.C. has nothing to disclose. C.B. has nothing to disclose. K.C. has nothing to disclose. G.C. has nothing to disclose. S.G. has nothing to disclose. P.J.H. has nothing to disclose. B.W.M. has nothing to disclose. T.M. has nothing to disclose. K.L.O’F.O’B. has nothing to disclose. R.H. has nothing to disclose. M.S. has nothing to disclose. D.T. has nothing to disclose.

Supported by NICHD grant R01-HD036455 to Kurt Barnhart. Ben Van Calster is a postdoctoral researcher funded by the Research Foundation, Flanders (FWO), Belgium. Norah M. van Mello and Petra Hajenius are supported by grants from The Netherlands Organisation for Health Research and Development (Agiko stipendium 920-03-328 and Clinical Fellow 40-00703-97-05-154).